Robert Landewéis a professor in rheumatology at the Academic Medical Center / University of Amsterdam, The Netherlands, and a consultant in Rheumatology at the Atrium Medical Center Heerlen, The Netherlands.
Professor Landewé received his medical degree from Maastricht University in 1990, and defended his thesis on cyclosporine therapy in rheumatoid arthritis in 1994. He received practical training in general internal medicine and rheumatology at Atrium Medical Center, Heerlen and in rheumatology at the University Hospital, Maastricht.
Currently, Professor Landewé is involved in outcome research and epidemiological research in the field of rheumatoid arthritis and spondyloarthritis. He has extensive experience in the design and analysis of clinical trials and has a special interest in medical statistics. Professor Landewé has authored or co-authored approximately 300 articles and many book chapters covering a variety of topics, but with an emphasis on clinical epidemiology, methodology, statistics and guideline development. He has led the EULAR recommendation initiatives on the management of early arthritis, the management of rheumatoid arthritis, and the measurement of disease activity in clinical trials. He is a regular reviewer for several general medicine-, rheumatology- and epidemiology journals.
Professor Landewé is a previous executive committee member of OMERACT, current president of the Assessment in Spondyloarthritis International Society (ASAS), executive board member of the Dutch Society of Rheumatology, and executive board member of the METEOR foundation (monitoring in rheumatology).